Author:
Ali Murad,Ashfaq Maryam,Tahir Butt Tariq,Gohar Shah Bushra,Bhatti Hammad Ur Rehman
Abstract
Ulcerative Colitis (UC) is a gastrointestinal issue, in which inflammation of the tract takes place. The disease level may be severe, moderate, or mild, so the detection method was selected according to the disease level. Finding the disease level and diagnostic method of UC is challenging. Objective: To find out a non-interfering way for the assessment of the activity of the disease, which is particularly important for the detection of UC. Therefore, the main goal of this study is to find a safe method for the determination of disease severity in the patients suffering from UC. Methods: For this study, 93 patients were selected suffering from UC (UC). For the assessment of all the specific parameters, C-Reactive Protein (CRP), Rate of erythrocytes sedimentation (ESR) and calprotectin in fecal, commonly used turbidimetric-immunoassay, Enzyme-linked immunosorbent assay (ELISA) and Westergren technique was used. A partial clinical score was used for the estimation of disease severity and the level of microalbuminuria was used determined by the immuno-turbidimetric way. Results: Among 93 patients suffering from UC, 37 patients were male and 56 patients were female. The average age of the patients was 40 plus. Microalbuminuria was present in more than 52 % of the patients. The presence of microalbuminuria depends upon the severity level of the disease, the most severe patients with Inflammatory bowel disease (IBD) have a large amount of microalbuminuria. The CRP, rate of sedimentation of erythrocytes, and other proteins level also vary with disease level. Conclusion: To measure the activity or severity level of the UC, microalbuminuria is considered a safe or non-interfering marker
Publisher
CrossLinks International Publishers
Reference24 articles.
1. 1. Khosla N, Sarafidis PA, Bakris GL. Microalbuminuria. Clin Lab Med. 2006 Sep;26(3):635-53, vi-vii. doi: 10.1016/j.cll.2006.06.005.
2. 2. Mahmud N, Stinson J, O'Connell MA, Mantle TJ, Keeling PW, Feely J, et al. Microalbuminuria in inflammatory bowel disease. Gut. 1994 Nov;35(11):1599-604. doi: 10.1136/gut.35.11.1599.
3. 3. Mahmud N, McDonald GS, Kelleher D, Weir DG. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut. 1996 Jan;38(1):99-103. doi: 10.1136/gut.38.1.99.
4. 4. Masnadi Shirazi K, Khayati S, Baradaran Binazir M, Nikniaz Z. Relationship between Microalbuminuria and Disease Activity in Patients with UC. Middle East J Dig Dis. 2020 Jan;12(1):34-38. doi: 10.15171/mejdd.2020.161.
5. 5. Marvisi M, Bassi E, Bonassi R, Civardi G, Delsignore R. DLCO correlates with intestinal inflammation in UC, but albuminuria does not. Minerva Gastroenterol Dietol. 2007 Dec;53(4):321-7.